Johnson & Johnson: all 3,718 studies

Page 28 of 38. Open to participants first (155), then studies with results posted, then the rest; newest registration first within each.

• Non-interventional Study on Use of Darunavir With Ritonavir in Clinical PracticeCompletedNCT01375881
• A Study of JNS002 (Doxorubicin Hydrochloride Liposome Injection) in Relapsed or Refractory Multiple MyelomaCompletedNCT01371227Phase 1
• Nicotine Pharmacodynamics With a New Oral Nicotine Replacement Therapy and Nicotine GumCompletedNCT01368016Not applicable
• A Pharmacodynamic Study of Dapoxetine Concomitantly Administered in Participants Taking TerazosinCompletedNCT01366664Phase 1
• A Study of Doripenem in CerebrospinalFluid After Doripenem Administration in Pediatric Patients Less Than 1 Year of AgeTerminatedNCT01366651Phase 1
• A Study to Assess the Relative Bioavailability of Two Abiraterone Acetate Suspension Formulations Compared to the Abiraterone Acetate Tablet Formulation in Healthy Adult VolunteersCompletedNCT01362764Phase 1
• Effect of JNJ 31001074 on Urge to Drink in Alcohol-Dependent AdultsWithdrawnNCT01362699Phase 2
• Paliperidone Palmitate Effectiveness Assessment Registry - Longitudinal (PEARL)CompletedNCT01362426
• A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)CompletedNCT01362153Phase 1
• A Study of [11C]JNJ-42491293, a Possible PET Ligand for the mGlu2 Receptor, in Healthy Adult VolunteersCompletedNCT01359852Phase 1
• A Dose-Ranging Study of JNJ-40411813 in Healthy Male VolunteersCompletedNCT01358006Phase 1
• A Long-Term Study on Safety of JNS001 in Adults With Attention-Deficit Hyperactivity DisorderCompletedNCT01357993Phase 3
• Immunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in NewbornsCompletedNCT01349283Phase 3
• Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary FibrosisWithdrawnNCT01346930Phase 2
• A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-39439335 in Patients With OsteoarthritisCompletedNCT01343303Phase 1
• The Effect of Food on the Administration of Canagliflozin in Healthy Adult VolunteersCompletedNCT01343290Phase 1
• A Pharmacokinetic Dose Proportionality Study of Canagliflozin in Healthy VolunteersCompletedNCT01340677Phase 1
• TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir.CompletedNCT01336829Phase 1
• "EASY EFFECTIVE SMOKELESS" With NICORETTE®CompletedNCT01323491
• TMC435-TiDP16-C115 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Erythromycin and Between TMC435 and Darunavir/Ritonavir (DRV/r)CompletedNCT01323257Phase 1
• A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 StudyCompletedNCT01323244Phase 3
• Investigation of the Safety, Tolerability and Potential Therapeutic Effects of JNJ-40411813 in Patients With SchizophreniaCompletedNCT01323205Phase 2
• To Test Bioequivalence Between Two Tablet Formulations in the Treatment of AllergyCompletedNCT01322282Phase 1
• Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement ProductsCompletedNCT01321931Phase 1
• A Study to Test Bioequivalence Between One Test Formulation of Ibuprofen and Two Reference TreatmentsCompletedNCT01316978Phase 1
• A Study of Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney FunctionCompletedNCT01309438Phase 1
• A Study to Compare the Dose-proportionality of Tapentadol (CG5503) in Healthy Japanese and Korean Male VolunteersCompletedNCT01309425Phase 1
• A Phase 1 Study of CNTO 328 (Siltuximab) in Relapsed or Refractory Multiple MyelomaTerminatedNCT01309412Phase 1
• An Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With SchizophreniaCompletedNCT01309373
• TMC114-TiDP3-C176 - A Study in Healthy Volunteers Investigating the Bioequivalence Between Two Commercially Available 400-mg Tablets to One New 800-mg Tablet of Darunavir (DRV) in the Presence of Low-dose Ritonavir Under Fed and Fasted ConditionsCompletedNCT01308658Phase 1
• TMC435-TiDP16-C116 - Relative Bioavailability and Food Effect StudyCompletedNCT01308606Phase 1
• Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR VaccinesCompletedNCT01307436Phase 3
• Bioequivalence Between a Racecadotril Capsule and Film-Coated Tablet (FCT) to Treat Diarrhea in AdultsCompletedNCT01302093Phase 1
• A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in KoreaCompletedNCT01294722
• A Pharmacodynamics, Pharmacokinetics, and Safety Study of Hydrochlorothiazide and Canagliflozin in Healthy VolunteersCompletedNCT01294631Phase 1
• TMC207TBC1003 - A Study in Healthy Volunteers Investigating the Effect of Single-dose TMC207 on the QT/QTc Interval Under Fed ConditionsCompletedNCT01291563Phase 1
• TMC278-TiDP6-C153 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC278 and RaltegravirCompletedNCT01288755Phase 1
• TMC435-TiDP16-C108 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Digoxin and Between TMC435 and RosuvastatinCompletedNCT01288742Phase 1
• TMC649128HPC1001 - First In-human Trial to Examine Safety, Tolerability, and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses of TMC649128 in Healthy VolunteersCompletedNCT01288677Phase 1
• A Safety, Tolerability, Pharmacokinetics, and Immunogenicity Study of CNTO 6785 in Healthy VolunteersCompletedNCT01288196Phase 1
• A Study of the Pharmacokinetics of Golimumab in Chinese Male SubjectsCompletedNCT01288157Phase 1
• A Pharmacokinetic and Pharmacodynamic Study of Once-Daily and Twice-Daily Dosing With Canagliflozin in Healthy Adult VolunteersCompletedNCT01286103Phase 1
• An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes MellitusTerminatedNCT01286090Phase 4
• Use of Demineralised Bone Matrix (DBX) in Osteochondritis Dissecans (OCD)WithdrawnNCT01283737Phase 4
• Case Series to Evaluate Patient Specific Implants (PSI) in Polyether Ether Ketone (PEEK) Performance After 2 YearsWithdrawnNCT01282645
• A Single and Multiple Dose Study of Canagliflozin in Healthy VolunteersCompletedNCT01281579Phase 1
• A Study of Cisapride in Premature Infants With Feeding ProblemsTerminatedNCT01281566Phase 4
• A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux DiseaseTerminatedNCT01281553Phase 4
• An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatment OptionsTerminatedNCT01281540Phase 4
• Paliperidone Palmitate Flexible Dosing in SchizophreniaCompletedNCT01281527Phase 3
• The Coherex FlatStent™ EF PFO Migraine RegistryTerminatedNCT01280578
• A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary DiseaseCompletedNCT01274507Early Phase 1
• A Pharmacokinetic and Pharmacodynamic Study of Metformin and Canagliflozin in Healthy Adult VolunteersCompletedNCT01273571Phase 1
• A Study of Two Methods for Determining the Renal Threshold for Glucose in Patients With Type 2 Diabetes MellitusCompletedNCT01273558Phase 1
• PRILIGY Usage Patterns in Selected PopulationsCompletedNCT01273545
• A Study to Compare the Bioequivalence of 50-mg Tapentadol (CG5503) Dose Administered as Two 50-mg Tablets Relative to One 100-mg TabletCompletedNCT01273532Phase 1
• A Study to Compare the Bioequivalence of 50-mg Tapentadol (CG5503) Dose Administered as Two 25-mg Tablets Relative to One 50-mg TabletCompletedNCT01273506Phase 1
• A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic DysfunctionCompletedNCT01273493Phase 1
• A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced MalignanciesCompletedNCT01273480Phase 1
• A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)CompletedNCT01273467Phase 1
• An Observational Study to Investigate Clinical Usefulness of OROS Hydromorphone in Korean Cancer PatientsCompletedNCT01273454
• An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus NephritisCompletedNCT01273389Phase 2
• Safety and Preliminary Efficacy Study of an Anti-inflammatory Therapeutic Antibody in Reducing Restenosis.CompletedNCT01270945Phase 2
• TMC435-TiDP16-C117: The Effect of TMC435 on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy VolunteersCompletedNCT01269294Phase 1
• A Phase I, Open-label Trial to Explore the Pharmacokinetics, Safety and Tolerability of TMC278 (Rilpivirine) 25 mg Once Daily Following a 2-week Period Receiving Efavirenz, in Healthy Male and Female VolunteersCompletedNCT01268839Phase 1
• A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced MalignanciesCompletedNCT01267084Phase 1/2
• A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple MyelomaWithdrawnNCT01266811Phase 3
• A Study to Assess the Clinical Profile of Patients in Spain With Moderate to Severe Psoriasis.CompletedNCT01262534
• Study of CA-18C3 in Subjects With Advanced Hematologic MalignanciesCompletedNCT01260545Phase 1
• A Study of Paliperidone Palmitate in Japanese Patients With SchizophreniaCompletedNCT01258920Phase 3
• A Study of the Pharmacokinetics of Golimumab in Japanese and Caucasian Male SubjectsCompletedNCT01258777Phase 1
• VX-950HEP1001 - Drug-drug Interaction Study Between Telaprevir and RaltegravirCompletedNCT01253551Phase 1
• TMC435-TiDP16-C123 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents Efavirenz and RaltegravirCompletedNCT01241773Phase 1
• A Study to Evaluate the Effectiveness of JNJ 40929837 for the Treatment of Asthma Using a Bronchial Allergen Challenge ModelCompletedNCT01241422Phase 2
• A Bioequivalence Study of 2 Formulations of Rabeprazole Sodium and Evaluation of the Effect of Food on Rabeprazole Sodium in Healthy Adult VolunteersCompletedNCT01241409Phase 1
• A Study to Record in an Observational Manner the Treatment of Multiple Myeloma as it is Being Done in Every Day Practice Without Providing Any Investigational Drug or Prescribing Any ProcedureCompletedNCT01241396
• Bioequivalence Between Two Oral Nicotine Sublingual Tablets, 2 mg and 4 mgCompletedNCT01238627Not applicable
• Becaplermin Use and Cancer Risk in a Patient Population of U.S. Veterans With DiabetesCompletedNCT01235260
• Single-dose Nicotine Pharmacokinetics With Four Oral Nicotine Replacement ProductsCompletedNCT01234896Not applicable
• Single-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products. A Study in Healthy Smokers.CompletedNCT01234792Not applicable
• An Open-Label Study of the Long-Term Safety of Dapoxetine HCl in the Treatment of Rapid EjaculationCompletedNCT01230762Phase 3
• RV568 - Viral Challenge With RSVCompletedNCT01230645Phase 1
• Vienna Challenge Chamber Study Using RV658 in Subjects With Allergic RhinitisCompletedNCT01230619Phase 2
• Single-dose Pharmacokinetics of Oral Nicotine Replacement ProductsCompletedNCT01228617Not applicable
• Rabies Virus Neutralizing Activity and Safety of CL184, a Monoclonal Antibody Cocktail, in Simulated Rabies Post-Exposure Prophylaxis in Healthy AdultsCompletedNCT01228383Phase 2
• Comparative Pharmacokinetic Study of New Oral Nicotine Replacement Therapy Products.CompletedNCT01227720Not applicable
• A Safety Study of CNTO 2476 in Patients With Age-Related Macular DegenerationCompletedNCT01226628Phase 1/2
• TMC435 HPC1004 - Phase I Study Investigating the Pharmacokinetics of TMC435 in Healthy Chinese VolunteersCompletedNCT01224197Phase 1
• Efficacy, Safety and Tolerability of Cadazolid in Subjects With Clostridium Difficile Associated Diarrhea (CDAD)CompletedNCT01222702Phase 2
• A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple MyelomaCompletedNCT01219010Phase 1
• Study of Abiraterone Acetate in Patients With Advanced Prostate CancerApproved for marketingNCT01217697
• Study to Evaluate Using a Cold Sore Patch to Treat Herpes LabialisCompletedNCT01208298Not applicable
• ACT-128800 in Patients With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT01208090Phase 2
• Coronary Sinus Reducer for Treatment of Refractory Angina - COSIRACompletedNCT01205893Phase 2
• TMC435-TiDP16-C114 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents TMC278 and TenofovirCompletedNCT01205139Phase 1
• A Study of the Safety and Efficacy of CNTO 888 in Combination With SoC (Standard of Care) Chemotherapy in Patients With Solid TumorsCompletedNCT01204996Phase 1
• Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's DiseaseCompletedNCT01203631Phase 2
• TMC647055HPC1001 - First-in-human Trial to Examine Safety, Tolerability and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses and of Increasing Repeated Oral Doses of TMC647055 in Healthy Volunteers and in Hepatitis C Virus Infected PatientsCompletedNCT01202825Phase 1
• A Pharmacokinetics and Safety of Methylphenidate HCl in Healthy Japanese Adult Male VolunteersCompletedNCT01202734Phase 1
• A Drug Interaction Study of Warfarin and Canagliflozin in Healthy Adult VolunteersCompletedNCT01195324Phase 1

← Johnson & Johnson overview and focus areas